Has FDA approved any type of clinical products including cannabis or cannabis-derived substances such as CBD?

FDA and Cannabis Derived Products

To date, the FDA has not approved a marketing application for cannabis for the treatment of any kind of disease or condition. FDA has, nevertheless, authorized one cannabis-derived and three cannabis-related medication products. These authorized products are only readily available with a prescription from a qualified doctor.

FDA has approved Epidiolex, which includes a detoxified kind of the medicine compound CBD for the treatment of seizures related to Lennox-Gastaut disorder or Dravet disorder in clients 2 years of age as well as older. That indicates FDA has actually wrapped up that this certain medicine item is risk-free and also effective for its intended usage.

The FDA has also accepted Marinol and Syndros for healing usages in the United States, for the treatment of anorexia associated with weight-loss in AIDS individuals. Marinol as well as Syndros consist of the energetic ingredient dronabinol, an artificial delta-9- tetrahydrocannabinol (THC) which is taken into consideration the psychedelic component of cannabis.

Another FDA-approved medication, Cesamet, includes the energetic ingredient nabilone, which has a chemical structure comparable to THC as well as is artificially obtained.

Related:

• What is FDA’s function when researching cannabis as well as cannabis-derived products for clinical use?
• Does the FDA object to the scientific investigation of marijuana for medical use?
• Hemp vs Cannabis